Enhancement of the uptake and cytotoxic activity of doxorubicin in cancer cells by novel cRGD-semipeptide-anchoring liposomes.

MLA

Battistini, Lucia, et al. “Enhancement of the Uptake and Cytotoxic Activity of Doxorubicin in Cancer Cells by Novel CRGD-Semipeptide-Anchoring Liposomes.” Molecular Pharmaceutics, vol. 11, no. 7, July 2014, pp. 2280–93. EBSCOhost, https://doi.org/10.1021/mp400718j.

APA

Battistini, L., Burreddu, P., Sartori, A., Arosio, D., Manzoni, L., Paduano, L., D’Errico, G., Sala, R., Reia, L., Bonomini, S., Rassu, G., & Zanardi, F. (2014). Enhancement of the uptake and cytotoxic activity of doxorubicin in cancer cells by novel cRGD-semipeptide-anchoring liposomes. Molecular Pharmaceutics, 11(7), 2280–2293. https://doi.org/10.1021/mp400718j

Chicago

Battistini, Lucia, Paola Burreddu, Andrea Sartori, Daniela Arosio, Leonardo Manzoni, Luigi Paduano, Gerardino D’Errico, et al. 2014. “Enhancement of the Uptake and Cytotoxic Activity of Doxorubicin in Cancer Cells by Novel CRGD-Semipeptide-Anchoring Liposomes.” Molecular Pharmaceutics 11 (7): 2280–93. doi:10.1021/mp400718j.